Results 111 to 120 of about 2,550 (172)
Bovine neonatal pancytopenia (BNP) was a vaccine-induced alloimmune disease observed in young calves and characterized by hemorrhages, pancytopenia, and severe destruction of the hematopoietic tissues.
Max Bastian (642021) +7 more
core +1 more source
Bovine neonatal pancytopenia (BNP) was a vaccine-induced alloimmune disease observed in young calves and characterized by hemorrhages, pancytopenia, and severe destruction of the hematopoietic tissues.
Max Bastian (642021) +15 more
core +1 more source
Abdullah Ahmed Meshi,1,* Hisham Abu-Tawil,2,3 Abdulrahman Ahmed Hamzi,1 Basem Ali Madkhali,4 Ali Bohais Maghfori,1 Ismail Ibrahim Alnami,3 Hassan A Hamali,5 Maymoon Mohammed Madkhali6,* 1Central Blood Bank, King Fahd Central Hospital, Ministry of
Meshi AA +7 more
doaj
Background: Antibodies against only about 25-28 blood group antigens are known to cause hemolytic reactions (HTRs), and red cell antibody screening should detect such clinically significant antibodies. An extension of the antibody screening test is the
Pathak Sangeeta +2 more
doaj
Clinical significance and persistence of alloantibodies in the hospital population
Uvod: Aloimunizacija je imunski odziv na antigene eritrocitov, s katerimi se bolnik sreča med transfuzijskim zdravljenjem, nosečnostjo ali transplantacijo. Imunski sistem prejemnika te antigene prepozna kot tuje in sproži tvorbo protiteles.
Hamelec, Lea
core
Platelet reactive alloantibodies responsible for immune thrombocytopenia in Malay population
Background: Alloantibodies against human platelet alloantigens (HPAs) are responsible for the development of platelet transfusion refractoriness (PTR) in patientsreceiving random platelets and bleeding disorder in babies with fetal neonatal alloimmune ...
Afifah Hassan +3 more
core
Alloantibodies in von Willebrand Disease
Abstractvon Willebrand disease (VWD), the most commonly known inherited bleeding disorder, is caused by a partial (type 1) or total (type 3) deficiency or dysfunction (type 2) of von Willebrand factor (VWF). Its management encompasses the prevention or treatment of bleeding by raising endogenous VWF levels using a synthetic agent, such as desmopressin,
Massimo, Franchini +1 more
openaire +3 more sources
Alloantibodies in congenital von Willebrand’s disease
In a review of the literature published in 1984 we identified (from 13 kindreds) 15 patients with severe von Willebrand's disease (vWD) reported to have developed alloantibodies. In order to reexamine the problem, a questionnaire was sent in 1989 to 141 hemophilia centers in America and Europe; 101 answers were received. These dealt with a total number
P. MANNUCCI, M. CATTANEO
openaire +4 more sources

